Skip to main content
Clinical Trials/NCT06608953
NCT06608953Enrolling By InvitationNot Applicable

A Prospective Randomized Controlled Trial of Effect of Enhanced External Counter Pulsation to Arterial Stiffness in Chronic Hemodialysis Patient

Thana Thongsricome, MD2 sites in 1 country14 target enrollmentStarted: February 13, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Sponsor
Enrollment
14
Locations
2
Primary Endpoint
Pulse wave velocity

Study Overview

Brief Summary

The objectives of this study are;

  • To study effect of Enhanced External Counter Pulsation on arterial stiffness, as measured by pulse wave velocity, compared to standard hemodialysis treatment.
  • To study effect of Enhanced External Counter Pulsation on central aortic blood pressure compared to standard hemodialysis treatment.
  • To study effect of Enhanced External Counter Pulsation on cardiac index decline during hemodialysis compared to standard hemodialysis treatment.
  • To study effect of Enhanced External Counter Pulsation on intradialytic hypotension events compared to standard hemodialysis treatment.
  • To study effect of Enhanced External Counter Pulsation on blood biomarkers for endothelial dysfunction and vascular inflammation compared to standard hemodialysis treatment.
  • To identify any adverse events from utilizing Enhanced External Counter Pulsation, such as pain or uncomfortable feeling, or even uncontrol hypertension.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

Dana analysis personnels are blinded to the reaserch arms. The subjects are not blinded to the treatment (not sham-controlled).

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Pulse wave velocity

Time Frame: Baseline, 1.5 months, and 3 months of research

Pulse wave velocity is a well-proven marker of arterial stiffness.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Thana Thongsricome, MD
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Thana Thongsricome, MD

Principal investigator

Chulalongkorn University

Study Sites (2)

Loading locations...

Similar Trials